Assyro AI

Orange Book product · Generic (ANDA)

IBANDRONATE SODIUM

IBANDRONATE SODIUM

Generic (ANDA)ANDA 078998TE ABRX ORBION PHARMS
View IBANDRONATE SODIUM familyOpen on FDA Orange Book

At a glance

Mar 19, 2012

Approved

Generic (ANDA)

Application

AB

TE code

None

Listed patents

Key dates

  1. Approval

    FDA approval date of this drug product.

    Mar 19, 2012

    14 yr 6 mo ago

  2. Today

Pharmaceutical detail

Active ingredient

IBANDRONATE SODIUM

Strength

EQ 150MG BASE

Dosage form

TABLET

Route

ORAL

TE code

AB

Application

ANDA 078998

Product number

001

Marketing status

RX

Reference listed drug (RLD)

No

Reference standard (RS)

No

Active-ingredient family

View full family

Generic (ANDA) of IBANDRONATE SODIUM

Listed patents

No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.

Book a Demo